Skip to main content
Erschienen in: Archives of Virology 8/2017

12.04.2017 | Original Article

Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses

verfasst von: Dulyatad Gronsang, Anh N. Bui, Dai Q. Trinh, Vuong N. Bui, Khong V. Nguyen, Minh X. Can, Tsutomu Omatsu, Tetsuya Mizutani, Makoto Nagai, Yukie Katayama, Rapeewan Thampaisarn, Haruko Ogawa, Kunitoshi Imai

Erschienen in: Archives of Virology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

H5N1 highly pathogenic avian influenza viruses (HPAIVs) are a threat to both animal and public health and require specific and rapid detection for prompt disease control. We produced three neutralizing anti-hemagglutinin (HA) monoclonal antibodies (mAbs) using two clades (2.2 and 2.5) of the H5N1 HPAIV isolated in Japan. Blocking immunofluorescence tests showed that each mAb recognized different epitopes; 3B5.1 and 3B5.2 mAbs against the clade 2.5 virus showed cross-clade reactivity to all 26 strains from clades 1, 2.2, 2.3.2.1, 2.3.2.1a, b, c and 2.3.4, suggesting that the epitope(s) recognized are conserved. Conversely, the 1G5 mAb against the clade 2.2 virus showed reactivity to only clades 1, 2.3.4 and 2.5 strains. An analysis of escape mutants, and some clades of the H5N1 viruses recognized by 3B5.1 and 3B5.2 mAbs, suggested that the mAbs bind to an epitope, including amino acid residues at position 162 in the HA1 protein (R162 and K162). Unexpectedly, however, when five Eurasian-origin H5 low-pathogenic AIV (LPAIV) strains with R162 were examined (EA-nonGsGD clade) as well as two American-origin strains (Am-nonGsGD clade), the mAb recognized only EA-nonGsGD clade strains. The R162 and K162 residues in the HA1 protein were highly conserved among 36 of the 43 H5N1 clades reported, including clades 2.3.2.1a and 2.3.2.1c that are currently circulating in Asia, Africa and Europe. The amino acid residues (158-PTIKRSYNNTNQE-170) in the HA1 protein are probably an epitope responsible for the cross-clade reactivity of the mAbs, considering the epitopes reported elsewhere. The 3B5.1 and 3B5.2 mAbs may be useful for the specific detection of H5N1 HPAIVs circulating in the field.
Literatur
1.
Zurück zum Zitat Chan PK (2002) Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 34(Suppl 2):S58–S64CrossRefPubMed Chan PK (2002) Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 34(Suppl 2):S58–S64CrossRefPubMed
2.
Zurück zum Zitat Brown IH (2010) Summary of avian influenza activity in Europe, Asia, and Africa, 2006–2009. Avian Dis 54:187–193CrossRefPubMed Brown IH (2010) Summary of avian influenza activity in Europe, Asia, and Africa, 2006–2009. Avian Dis 54:187–193CrossRefPubMed
3.
Zurück zum Zitat Amendola A, Ranghiero A, Zanetti A, Pariani E (2011) Is avian influenza virus A(H5N1) a real threat to human health? J Prev Med Hyg 52:107–110PubMed Amendola A, Ranghiero A, Zanetti A, Pariani E (2011) Is avian influenza virus A(H5N1) a real threat to human health? J Prev Med Hyg 52:107–110PubMed
5.
Zurück zum Zitat WHO/OIE/FAO, H5N1 Evolution Working Group (2008) Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 14:e1CrossRef WHO/OIE/FAO, H5N1 Evolution Working Group (2008) Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 14:e1CrossRef
6.
Zurück zum Zitat WHO/OIE/FAO, H5N1 Evolution Working Group (2014) Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza Other Respir Viruses 8:384–388CrossRef WHO/OIE/FAO, H5N1 Evolution Working Group (2014) Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza Other Respir Viruses 8:384–388CrossRef
7.
Zurück zum Zitat WHO/OIE/FAO, H5N1 Evolution Working Group (2012) Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respir Viruses 6:1–5CrossRef WHO/OIE/FAO, H5N1 Evolution Working Group (2012) Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respir Viruses 6:1–5CrossRef
8.
Zurück zum Zitat Smith GJ, Donis RO, WHO/OIE/FAO, H5 Evolution Working Group (2015) Nomenclature updates resulting from the evolution of avian influenza A (H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir Viruses 9:271–276CrossRef Smith GJ, Donis RO, WHO/OIE/FAO, H5 Evolution Working Group (2015) Nomenclature updates resulting from the evolution of avian influenza A (H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir Viruses 9:271–276CrossRef
12.
Zurück zum Zitat Swayne DE (2007) Understanding the complex pathobiology of high pathogenicity avian influenza viruses in birds. Avian Dis 51(1 Suppl):242–249CrossRefPubMed Swayne DE (2007) Understanding the complex pathobiology of high pathogenicity avian influenza viruses in birds. Avian Dis 51(1 Suppl):242–249CrossRefPubMed
13.
Zurück zum Zitat Spackman E, Swayne DE, Suarez DL, Senne DA, Pedersen JC, Killian ML, Pasick JK, Handel K, Lee CW, Stallknecht D, Slemons R, Ip HS, Deliberto T (2007) Characterization of low-pathogenicity H5N1 avian influenza viruses from North America. J Virol 81(21):11612–11619CrossRefPubMedPubMedCentral Spackman E, Swayne DE, Suarez DL, Senne DA, Pedersen JC, Killian ML, Pasick JK, Handel K, Lee CW, Stallknecht D, Slemons R, Ip HS, Deliberto T (2007) Characterization of low-pathogenicity H5N1 avian influenza viruses from North America. J Virol 81(21):11612–11619CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ohnishi K, Takahashi Y, Kono N, Nakajima N, Mizukoshi F, Misawa S, Yamamoto T, Mitsuki YY, Fu S, Hirayama N, Ohshima M, Ato M, Kageyama T, Odagiri T, Tashiro M, Kobayashi K, Itamura S, Tsunetsugu-Yokota Y (2012) Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus. Jpn J Infect Dis 65:19–27CrossRefPubMed Ohnishi K, Takahashi Y, Kono N, Nakajima N, Mizukoshi F, Misawa S, Yamamoto T, Mitsuki YY, Fu S, Hirayama N, Ohshima M, Ato M, Kageyama T, Odagiri T, Tashiro M, Kobayashi K, Itamura S, Tsunetsugu-Yokota Y (2012) Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus. Jpn J Infect Dis 65:19–27CrossRefPubMed
15.
Zurück zum Zitat Du A, Daidoji T, Koma T, Ibrahim MS, Nakamura S, de Silva UC, Ueda M, Yang CS, Yasunaga T, Ikuta K, Nakaya T (2009) Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody. Biochem Biophys Res Commun 378:197–202CrossRefPubMed Du A, Daidoji T, Koma T, Ibrahim MS, Nakamura S, de Silva UC, Ueda M, Yang CS, Yasunaga T, Ikuta K, Nakaya T (2009) Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody. Biochem Biophys Res Commun 378:197–202CrossRefPubMed
16.
Zurück zum Zitat Wada A, Sakoda Y, Oyamada T, Kida H (2011) Development of a highly sensitive immunochromatographic detection kit for H5 influenza virus hemagglutinin using silver amplification. J Virol Methods 178:82–86CrossRefPubMed Wada A, Sakoda Y, Oyamada T, Kida H (2011) Development of a highly sensitive immunochromatographic detection kit for H5 influenza virus hemagglutinin using silver amplification. J Virol Methods 178:82–86CrossRefPubMed
17.
Zurück zum Zitat Kobayashi-Ishihara M, Takahashi H, Ohnishi K, Nishimura K, Terahara K, Ato M, Itamura S, Kageyama T, Tsunetsugu-Yokota Y (2014) Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin. PLoS One 9:e99201CrossRefPubMedPubMedCentral Kobayashi-Ishihara M, Takahashi H, Ohnishi K, Nishimura K, Terahara K, Ato M, Itamura S, Kageyama T, Tsunetsugu-Yokota Y (2014) Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin. PLoS One 9:e99201CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Wu R, Li X, Leung HC, Cao Z, Qiu Z, Zhou Y, Zheng BJ, He Y (2014) A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission. Antiviral Res 106:13–23CrossRefPubMed Wu R, Li X, Leung HC, Cao Z, Qiu Z, Zhou Y, Zheng BJ, He Y (2014) A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission. Antiviral Res 106:13–23CrossRefPubMed
19.
Zurück zum Zitat Hu H, Voss J, Zhang G, Buchy P, Zuo T, Wang L, Wang F, Zhou F, Wang G, Tsai C, Calder L, Gamblin SJ, Zhang L, Deubel V, Zhou B, Skehel JJ, Zhou P (2012) A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses. J Virol 86:2978–2989CrossRefPubMedPubMedCentral Hu H, Voss J, Zhang G, Buchy P, Zuo T, Wang L, Wang F, Zhou F, Wang G, Tsai C, Calder L, Gamblin SJ, Zhang L, Deubel V, Zhou B, Skehel JJ, Zhou P (2012) A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses. J Virol 86:2978–2989CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Xiong X, Corti D, Liu J, Pinna D, Foglierini M, Calder LJ, Martin SR, Lin YP, Walker PA, Collins PJ, Monne I, Suguitan AL Jr, Santos C, Temperton NJ, Subbarao K, Lanzavecchia A, Gamblin SJ, Skehel JJ (2015) Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody. Proc Natl Acad Sci U S A 112:9430–9435CrossRefPubMedPubMedCentral Xiong X, Corti D, Liu J, Pinna D, Foglierini M, Calder LJ, Martin SR, Lin YP, Walker PA, Collins PJ, Monne I, Suguitan AL Jr, Santos C, Temperton NJ, Subbarao K, Lanzavecchia A, Gamblin SJ, Skehel JJ (2015) Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody. Proc Natl Acad Sci U S A 112:9430–9435CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Imai K, Ogawa H, Bui VN, Inoue H, Fukuda J, Ohba M, Yamamoto Y, Nakamura K (2012) Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials. Antiviral Res 93:225–233CrossRefPubMed Imai K, Ogawa H, Bui VN, Inoue H, Fukuda J, Ohba M, Yamamoto Y, Nakamura K (2012) Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials. Antiviral Res 93:225–233CrossRefPubMed
22.
Zurück zum Zitat Trinh DQ, Ogawa H, Bui VN, Baatartsogt T, Kizito MK, Yamaguchi S, Imai K (2015) Characterization of mAbs to chicken anemia virus and epitope mapping on its viral protein, VP1. J Gen Virol 96:1086–1097CrossRefPubMed Trinh DQ, Ogawa H, Bui VN, Baatartsogt T, Kizito MK, Yamaguchi S, Imai K (2015) Characterization of mAbs to chicken anemia virus and epitope mapping on its viral protein, VP1. J Gen Virol 96:1086–1097CrossRefPubMed
23.
Zurück zum Zitat Harlow E, Lane D (1988) Antibodies A Laboratory Manual. Cold Spring Harbor Laboratory, New York Harlow E, Lane D (1988) Antibodies A Laboratory Manual. Cold Spring Harbor Laboratory, New York
24.
Zurück zum Zitat Nishikawa K, Isomura S, Suzuki S, Watanabe E, Hamaguchi M, Yoshida T, Nagai Y (1983) Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons. Virology 130:318–330CrossRefPubMed Nishikawa K, Isomura S, Suzuki S, Watanabe E, Hamaguchi M, Yoshida T, Nagai Y (1983) Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons. Virology 130:318–330CrossRefPubMed
26.
Zurück zum Zitat Behrens B, Kärber G (1934) Wie sind Reihenversuche für biologishe Auswertungen am zweckmäßigsten anzuordnen [in German]? Naunyn Schmiedebergs. Arch Exp Pathol Pharmakol 18:379–388CrossRef Behrens B, Kärber G (1934) Wie sind Reihenversuche für biologishe Auswertungen am zweckmäßigsten anzuordnen [in German]? Naunyn Schmiedebergs. Arch Exp Pathol Pharmakol 18:379–388CrossRef
27.
Zurück zum Zitat Masuda T, Nagai M, Yamasato H, Tsuchiaka S, Okazaki S, Katayama Y, Oba M, Nishiura N, Sassa Y, Omatsu T, Furuya T, Koyama S, Shirai J, Taniguchi K, Fujii Y, Todaka R, Katayama K, Mizutani T (2014) Identification of novel bovine group A rotavirus G15P[14] strain from epizootic diarrhea of adult cows by de novo sequencing using a next-generation sequencer. Vet Microbiol 171:66–73CrossRefPubMed Masuda T, Nagai M, Yamasato H, Tsuchiaka S, Okazaki S, Katayama Y, Oba M, Nishiura N, Sassa Y, Omatsu T, Furuya T, Koyama S, Shirai J, Taniguchi K, Fujii Y, Todaka R, Katayama K, Mizutani T (2014) Identification of novel bovine group A rotavirus G15P[14] strain from epizootic diarrhea of adult cows by de novo sequencing using a next-generation sequencer. Vet Microbiol 171:66–73CrossRefPubMed
28.
Zurück zum Zitat Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protocols 10:845–858CrossRefPubMed Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protocols 10:845–858CrossRefPubMed
30.
Zurück zum Zitat Mase M, Eto M, Tanimura N, Imai K, Tsukamoto K, Horimoto T, Kawaoka Y, Yamaguchi S (2005) Isolation of a genotypically unique H5N1 influenza virus from duck meat imported into Japan from China. Virology 339:101–109CrossRefPubMed Mase M, Eto M, Tanimura N, Imai K, Tsukamoto K, Horimoto T, Kawaoka Y, Yamaguchi S (2005) Isolation of a genotypically unique H5N1 influenza virus from duck meat imported into Japan from China. Virology 339:101–109CrossRefPubMed
31.
Zurück zum Zitat Suzuki K, Okada H, Itoh T, Tada T, Tsukamoto K (2010) Phenotypes influencing the transmissibility of highly pathogenic avian influenza viruses in chickens. J Gen Virol 91:2302–2306CrossRefPubMed Suzuki K, Okada H, Itoh T, Tada T, Tsukamoto K (2010) Phenotypes influencing the transmissibility of highly pathogenic avian influenza viruses in chickens. J Gen Virol 91:2302–2306CrossRefPubMed
32.
Zurück zum Zitat Bui VN, Ogawa H, Ngo LH, Baatartsogt T, Abao LN, Tamaki S, Saito K, Watanabe Y, Runstadler J, Imai K (2013) H5N1 highly pathogenic avian influenza virus isolated from conjunctiva of a whooper swan with neurological signs. Arch Virol 158:451–455CrossRefPubMed Bui VN, Ogawa H, Ngo LH, Baatartsogt T, Abao LN, Tamaki S, Saito K, Watanabe Y, Runstadler J, Imai K (2013) H5N1 highly pathogenic avian influenza virus isolated from conjunctiva of a whooper swan with neurological signs. Arch Virol 158:451–455CrossRefPubMed
33.
Zurück zum Zitat Okamatsu M, Tanaka T, Yamamoto N, Sakoda Y, Sasaki T, Tsuda Y, Isoda N, Kokumai N, Takada A, Umemura T, Kida H (2010) Antigenic, genetic, and pathogenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from dead whooper swans (Cygnus cygnus) found in northern Japan in 2008. Virus Genes 41:351–357CrossRefPubMed Okamatsu M, Tanaka T, Yamamoto N, Sakoda Y, Sasaki T, Tsuda Y, Isoda N, Kokumai N, Takada A, Umemura T, Kida H (2010) Antigenic, genetic, and pathogenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from dead whooper swans (Cygnus cygnus) found in northern Japan in 2008. Virus Genes 41:351–357CrossRefPubMed
34.
Zurück zum Zitat Yamamoto N, Sakoda Y, Motoshima M, Yoshino F, Soda K, Okamatsu M, Kida H (2011) Characterization of a non-pathogenic H5N1 influenza virus isolated from a migratory duck flying from Siberia in Hokkaido, Japan, in October 2009. Virol J 8:65CrossRefPubMedPubMedCentral Yamamoto N, Sakoda Y, Motoshima M, Yoshino F, Soda K, Okamatsu M, Kida H (2011) Characterization of a non-pathogenic H5N1 influenza virus isolated from a migratory duck flying from Siberia in Hokkaido, Japan, in October 2009. Virol J 8:65CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Okamatsu M, Saito T, Yamamoto Y, Mase M, Tsuduku S, Nakamura K, Tsukamoto K, Yamaguchi S (2007) Low pathogenicity H5N2 avian influenza outbreak in Japan during the 2005-2006. Vet Microbiol 124:35–46CrossRefPubMed Okamatsu M, Saito T, Yamamoto Y, Mase M, Tsuduku S, Nakamura K, Tsukamoto K, Yamaguchi S (2007) Low pathogenicity H5N2 avian influenza outbreak in Japan during the 2005-2006. Vet Microbiol 124:35–46CrossRefPubMed
36.
Zurück zum Zitat Eto M, Mase M (2003) Isolation of the newcastle disease virus and the H9N2 influenza A virus from chicken imported from China. J Japan Vet Med Assoc 56:333–339CrossRef Eto M, Mase M (2003) Isolation of the newcastle disease virus and the H9N2 influenza A virus from chicken imported from China. J Japan Vet Med Assoc 56:333–339CrossRef
37.
Zurück zum Zitat Rudneva IA, Kushch AA, Masalova OV, Timofeeva TA, Klimova RR, Shilov AA, Ignatieva AV, Krylov PS, Kaverin NV (2010) Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus. Viral Immunol 23:181–187CrossRefPubMed Rudneva IA, Kushch AA, Masalova OV, Timofeeva TA, Klimova RR, Shilov AA, Ignatieva AV, Krylov PS, Kaverin NV (2010) Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus. Viral Immunol 23:181–187CrossRefPubMed
38.
Zurück zum Zitat Shore DA, Yang H, Balish AL, Shepard SS, Carney PJ, Chang JC, Davis CT, Donis RO, Villanueva JM, Klimov AI, Stevens J (2013) Structural and antigenic variation among diverse clade 2 H5N1 viruses. PLoS One 8:e75209CrossRefPubMedPubMedCentral Shore DA, Yang H, Balish AL, Shepard SS, Carney PJ, Chang JC, Davis CT, Donis RO, Villanueva JM, Klimov AI, Stevens J (2013) Structural and antigenic variation among diverse clade 2 H5N1 viruses. PLoS One 8:e75209CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Yang H, Carney PJ, Mishin VP, Guo Z, Chang JC, Wentworth DE, Gubareva LV, Stevens J (2016) Molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses. J Virol 90:5770–5784CrossRefPubMedPubMedCentral Yang H, Carney PJ, Mishin VP, Guo Z, Chang JC, Wentworth DE, Gubareva LV, Stevens J (2016) Molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses. J Virol 90:5770–5784CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG (2007) Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 81:12911–12917CrossRefPubMedPubMedCentral Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG (2007) Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 81:12911–12917CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Masalova OV, Klimova RR, Chichev EV, Fediakina IT, Loginova SY, Borisevich SV, Bondarev VP, Deryabin PG, Lvov DK, Kushch AA (2011) Development of monoclonal antibodies to highly pathogenic avian influenza H5N1 virus and their application to diagnostics, prophylaxis, and therapy. Acta Virol 55:3–14CrossRefPubMed Masalova OV, Klimova RR, Chichev EV, Fediakina IT, Loginova SY, Borisevich SV, Bondarev VP, Deryabin PG, Lvov DK, Kushch AA (2011) Development of monoclonal antibodies to highly pathogenic avian influenza H5N1 virus and their application to diagnostics, prophylaxis, and therapy. Acta Virol 55:3–14CrossRefPubMed
42.
Zurück zum Zitat Rudneva IA, Kushch AA, Masalova OV, Timofeeva TA, Klimova RR, Shilov AA, Ignatieva AV, Krylov PS, Kaverin NV (2010) Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus. Viral Immunol 23:181–187CrossRefPubMed Rudneva IA, Kushch AA, Masalova OV, Timofeeva TA, Klimova RR, Shilov AA, Ignatieva AV, Krylov PS, Kaverin NV (2010) Antigenic epitopes in the hemagglutinin of Qinghai-type influenza H5N1 virus. Viral Immunol 23:181–187CrossRefPubMed
43.
Zurück zum Zitat Zuo T, Sun J, Wang G, Jiang L, Zuo Y, Li D, Shi X, Liu X, Fan S, Ren H, Hu H, Sun L, Zhou B, Liang M, Zhou P, Wang X, Zhang L (2015) Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection. Nat Commun 6:8855CrossRefPubMedPubMedCentral Zuo T, Sun J, Wang G, Jiang L, Zuo Y, Li D, Shi X, Liu X, Fan S, Ren H, Hu H, Sun L, Zhou B, Liang M, Zhou P, Wang X, Zhang L (2015) Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection. Nat Commun 6:8855CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat He F, Soejoedono RD, Murtini S, Goutama M, Kwang J (2010) Complementary monoclonal antibody-based dot ELISA for universal detection of H5 avian influenza virus. BMC Microbiol 10:330CrossRefPubMedPubMedCentral He F, Soejoedono RD, Murtini S, Goutama M, Kwang J (2010) Complementary monoclonal antibody-based dot ELISA for universal detection of H5 avian influenza virus. BMC Microbiol 10:330CrossRefPubMedPubMedCentral
Metadaten
Titel
Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses
verfasst von
Dulyatad Gronsang
Anh N. Bui
Dai Q. Trinh
Vuong N. Bui
Khong V. Nguyen
Minh X. Can
Tsutomu Omatsu
Tetsuya Mizutani
Makoto Nagai
Yukie Katayama
Rapeewan Thampaisarn
Haruko Ogawa
Kunitoshi Imai
Publikationsdatum
12.04.2017
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 8/2017
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3350-0

Weitere Artikel der Ausgabe 8/2017

Archives of Virology 8/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.